US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Ophthalmology Market Research Reports & Industry Analysis

A portion of ophthalmology that resists change unlike some other specialties is the consumer reluctance to undertake a procedure that may have side effects associated with vision like refractive laser correction. Any side effects concerning eyes/vision is typically avoided as much as possible especially if there are other options.
Typically if the out-of pocket price for a life-enhancing procedure is within the budget of a consumer, the patient has a strong desire to get the procedure, and other factors are present that allow for it, the procedure is undertaken. In laser correction there has been skepticism which has diminished as more patients undertake the procedure with good results. While new ideas, breakthrough technologies, cost efficiencies, increased productivity,and new markets are the keys to growth and competitiveness, most people [work force; consumers; academics; politicians] are more confident in familiar environments. They will resist change unless their job, livelihood, or lifestyles are threatened.

This phenomenon is partly responsible for the trend toward closing solo and small group practices to join vision care networks. Though this experience exists more in general medical practices and some pecialties, ophthalmologists also face the threat of practitioners [osteopathic physicians, doctors of optometry] replacing eye MDs—an intrusion on their medical training, skills, and specialty. However increasing healthcare costs, and economic changes sometimes force shifts in the typical work pattern of healthcare providers. One example is a change that has happened in states across the U.S. allowing optometrists to diagnose and treat glaucoma.

RSS Feeds

Ophthalmology Industry Research & Market Reports

< prev 1    3  4  5  6  7  8  9  10  
Global Age-Related Macular Degeneration Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... Patient Flow Analysis - 2015’. The report provides insights into Age-Related Macular Degeneration epidemiology, Age-Related Macular Degeneration diagnosed patients, and Age-Related Macular Degeneration treatment rate for top seven pharmaceutical markets. The study measures key indicators ...  |  read more...
USD 1,200
Global Glaucoma Epidemiology and Patient Flow Analysis - 2015
1/9/2015 | published by: Fore Pharma
... report provides insights into Glaucoma epidemiology, Glaucoma diagnosed patients, and Glaucoma treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Glaucoma derived from epidemiological analysis, percentage of patients ...  |  read more...
USD 1,200
Gene Therapy Ophthalmology Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape
1/1/2015 | published by: DelveInsight
... chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. The Gene Therapy Ophthalmology Report provides the target gene name, localization of gene, molecular function of target with ...  |  read more...
USD 3,000
Manufacturing Opticians (UK) - Industry Report
1/5/2015 | published by: Plimsoll Publishing Ltd.
... graphical analysis – analysing the 210 largest Manufacturing Opticians (UK) companies. The Manufacturing Opticians (UK) report contains the most-up-to-date financial data and Plimsoll applies these figures to create their unique and authoritative analysis. Indeed, the ...  |  read more...
USD 560
Global Perimetry Industry 2014 Market Research Report
12/22/2014 | published by: 9Dimen Research
... region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introducedPeripheral Vascular Stents basic information includingPeripheral Vascular Stents definition, classification, application and ...  |  read more...
USD 2,850
Corneal Ulcers - Pipeline Review, H2 2014
12/31/2014 | published by: Global Markets Direct
... therapeutic development for Corneal Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Age-related Macular Degeneration Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... age-related macular degeneration partnering deals Top age-related macular degeneration deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Age-related Macular Degeneration Partnering 2009-2014 provides understanding and access to the ...  |  read more...
USD 695
Glaucoma Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Glaucoma Partnering 2009-2014 provides understanding and access to the glaucoma partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Ophthalmology Pipeline Highlights Database – 2015
11/5/2014 | published by: Fore Pharma
... active clinical development stages including early and late stage clinical trials. Key indications covered in this report include Conjunctivitis, Glaucoma, Diabetic Retinopathy, Myasthenia gravis, Dry Eye Syndrome, Age-related Macular Degeneration, and Cataract. The pipeline data ...  |  read more...
USD 2,800
Ocular Inflammation Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the different countries ...  |  read more...
USD 2,000
Wet (Neovascular / Exudative) Macular Degeneration Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and ...  |  read more...
USD 2,000
Ocular Inflammation-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Ocular Inflammation. This report provides information on the therapeutic development based on the Ocular Inflammation dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Ocular Pain-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Ocular Pain. This report provides information on the therapeutic development based on the Ocular Pain dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Eye Infections-Pipeline Insights, 2014
11/21/2014 | published by: DelveInsight
... pipeline drugs that fall under Eye Infections. This report provides information on the therapeutic development based on the Eye Infections dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, ...  |  read more...
USD 1,250
Ophthalmologists: State Industry Market Evaluator 621111.07
12/1/2014 | published by: BizMiner
... for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, ...  |  read more...
USD 599
Offices of Optometrists: State Industry Market Evaluator 621320
12/1/2014 | published by: BizMiner
... are displayed for 2011-2012-2013-2014q2 for these measures: industry market volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure ...  |  read more...
USD 599
Global Corneal Topography Industry
11/2/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Corneal Topography basic information including Corneal Topography definition, classification, ...  |  read more...
USD 2,850
Global Non-contact Tonometer Industry
11/2/2014 | published by: 9Dimen Research
... the main region including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Non-contact Tonometer basic information including Non-contact Tonometer definition, classification, ...  |  read more...
USD 2,850
Global Focimeter Industry
11/2/2014 | published by: 9Dimen Research
... including North American, Europe and Asia etc, and the main country including United States ,Germany ,Japan and China etc. The report firstly introduced Focimeter basic information including Focimeter definition, classification, application and industry chain overview; ...  |  read more...
USD 2,850
Cataract - Pipeline Review, H2 2014
11/14/2014 | published by: Global Markets Direct
... Cataract, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It ...  |  read more...
USD 2,000
Ophthalmics Partnering Terms & Agreements
12/1/2014 | published by: Current Partnering
... or development stage whereby the licensee obtains a right or an option right to license the licensors ophthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report ...  |  read more...
USD 1,995
Retinal Degeneration - Pipeline Review, H2 2014
12/10/2014 | published by: Global Markets Direct
... therapeutic development for Retinal Degeneration, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Conjunctivitis Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... by value Deals listed by company A-Z, industry sector, stage of development, technology type Conjunctivitis Partnering 2009-2014 provides understanding and access to the conjunctivitis partnering deals and agreements entered into by the worlds leading healthcare ...  |  read more...
USD 695
Dry Eye Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... deals Top dry eye deals by value Deals listed by company A-Z, industry sector, stage of development, technology type Dry Eye Partnering 2009-2014 provides understanding and access to the dry eye partnering deals and agreements ...  |  read more...
USD 695
Age-Related Macular Degeneration Pipeline Highlights – 2015
11/5/2014 | published by: Fore Pharma
... emerging therapies for Age-Related Macular Degeneration in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating ...  |  read more...
USD 670
< prev 1    3  4  5  6  7  8  9  10